Literature DB >> 16678598

Extracorporeal life support after staged palliation of a functional single ventricle: subsequent morbidity and survival.

Aparna Hoskote1, Desmond Bohn, Colleen Gruenwald, David Edgell, Sally Cai, Ian Adatia, Glen Van Arsdell.   

Abstract

OBJECTIVE: We sought to review the outcome of infants with a functional single ventricle receiving postoperative extracorporeal life support.
METHODS: We reviewed all patients with a functional single ventricle receiving postoperative extracorporeal life support between January 1997 and May 2003.
RESULTS: We supported 25 infants (age range, 2-139 days; median age, 15 days; weight range, 1.9-5.9 kg; median weight, 3.4 kg) with extracorporeal life support. Operative procedures were Norwood stage 1 procedure in 18 patients, modified Blalock-Taussig shunt in 4 patients, bidirectional superior cavopulmonary shunt in 2 patients, and pulmonary vein repair in 1 patient. Indications for extracorporeal life support included cardiac arrest (14/25) and low cardiac output state (11/25). Extracorporeal membrane oxygenation was initiated in 19 patients, with conversion to a ventricular assist device in 7 patients. Ventricular assist device alone was initiated in 6 patients. Survival to decannulation was 76%, with 5 late deaths from multiorgan failure and 56% intensive care unit survival. Survival to hospital discharge was 44%. On univariate analysis, the presence of arrhythmia before extracorporeal life support (P = .005), renal failure (P = .0007), Candida species-induced sepsis (P = .026), and multiorgan failure (P = .0009) were significant risk factors in the nonsurvivors. Median hospital stay was 43.5 days (range, 6-181 days) for the whole group and 93 days (range, 36-181 days) for survivors. Eight patients completed next stage palliation.
CONCLUSIONS: Twenty percent of patients were supported with a ventricular assist device alone, with 50% conversion to a ventricular assist device from extracorporeal membrane oxygenation. Survival to decannulation was encouraging. Multiorgan failure and risk of invasive infection in the post-extracorporeal membrane oxygenation period mitigate against survival to hospital discharge. Use of extracorporeal life support before cardiac arrest might reduce attrition between decannulation and hospital discharge.

Entities:  

Mesh:

Year:  2006        PMID: 16678598     DOI: 10.1016/j.jtcvs.2005.11.035

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  16 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

3.  Post-cardiotomy Rescue Extracorporeal Cardiopulmonary Resuscitation in Neonates with Single Ventricle After Intractable Cardiac Arrest: Attrition After Hospital Discharge and Predictors of Outcome.

Authors:  Anastasios C Polimenakos; Vincent Rizzo; Chawki F El-Zein; Michel N Ilbawi
Journal:  Pediatr Cardiol       Date:  2016-11-24       Impact factor: 1.655

Review 4.  Options for the failing ventricle in pediatric heart disease.

Authors:  Mazyar Kanani; Tain-Yen Hsia
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

5.  Interstage Survival for Patients with Hypoplastic Left Heart Syndrome After ECMO.

Authors:  Richard P Fernandez; Brian F Joy; Robin Allen; Jamie Stewart; Holly Miller-Tate; Yongjie Miao; Lisa Nicholson; Clifford L Cua
Journal:  Pediatr Cardiol       Date:  2016-11-01       Impact factor: 1.655

6.  Early clinical outcomes of new pediatric extracorporeal life support system (Endumo (2000) in neonates and infants.

Authors:  Takaya Hoashi; Koji Kagisaki; Kizuku Yamashita; Eisuke Tatsumi; Takayuki Nishigaki; Kotaro Yoshida; Teruyuki Hayashi; Hajime Ichikawa
Journal:  J Artif Organs       Date:  2013-05-30       Impact factor: 1.731

Review 7.  An overview of mechanical circulatory support in single-ventricle patients.

Authors:  Jacob R Miller; Timothy S Lancaster; Connor Callahan; Aaron M Abarbanell; Pirooz Eghtesady
Journal:  Transl Pediatr       Date:  2018-04

8.  Donation after cardiocirculatory death: a call for a moratorium pending full public disclosure and fully informed consent.

Authors:  Ari R Joffe; Joe Carcillo; Natalie Anton; Allan deCaen; Yong Y Han; Michael J Bell; Frank A Maffei; John Sullivan; James Thomas; Gonzalo Garcia-Guerra
Journal:  Philos Ethics Humanit Med       Date:  2011-12-29       Impact factor: 2.464

9.  Postcardiotomy Extracorporeal Membrane Oxygenation Support in Patients with Congenital Heart Disease.

Authors:  Seohee Joo; Sungkyu Cho; Jae Hong Lee; Jooncheol Min; Hye Won Kwon; Jae Gun Kwak; Woong-Han Kim
Journal:  J Chest Surg       Date:  2022-04-05

10.  Factors influencing the outcome of paediatric cardiac surgical patients during extracorporeal circulatory support.

Authors:  Sendhil K Balasubramanian; Ravindranath Tiruvoipati; Mohammed Amin; Kanakkande K Aabideen; Giles J Peek; Andrew W Sosnowski; Richard K Firmin
Journal:  J Cardiothorac Surg       Date:  2007-01-11       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.